San Francisco, May 28 (IANS) The latest version of activity trackers and wearables maker Fitbit's app will help detect nighttime snoring and noise along with various other sleep features.With Fitbit 3.42 rolling out via the Play Store, Google's acquired health app is preparing for the trackers to be used to help determine why you might not be sleeping well or feeling unrested in the morning.With "Snore & Noise Detect" enabled, Fitbit will turn its microphone on when it detects that the users have fallen asleep, then begin listening to the ambient noise including your potential snoring, 9To5Google reported.Disregarding any detected snores, Fitbit will also be able to tell how loud the ambient noise is in the bedroom, on a scale of "very quiet" to "very loud".Fitbit is also working on another sleep-related feature, entitled "Your sleep animal".Unlike snore detection, things seem to still be very early in development as most of the relevant text is currently a placeholder, the report said.The company recently announced that it is finally rolling out support for two-factor authentication (2FA).Fitbit users on Android and iOS are beginning to see a "Increase your security" prompt that explains how "two-factor authentication gives you an extra layer of protection".Fitbit's 2FA system sees codes sent to the user's phone via SMS. It's not the most secure method, given carrier spoofing, but better than nothing at this point.--IANSvc/vd
San Francisco, April 8 (IANS) Wearable brand Fitbit is investigating whether it can measure blood pressure with a new study for Sense smartwatch users.Fitbit Sense comes with electrodermal activity (EDA) to measure daily stress and comes with a heart rate tracker, electrocardiogram (ECG) monitor and skin temperature sensors.According to 9To5Google, Fitbit Labs is launching a blood pressure study this month to "potentially measure" Pulse Arrival Time (PAT), or the "time it takes for a pulse of blood to reach your wrist after your heart beats". The company wants to "explore the potential link to tracking blood pressure" and needs a wider data set, the report said.Previous research has found a correlation between PAT and blood pressure, but the correlation was not strong enough to predict blood pressure. These investigations were limited to either small data sets or specific environments like an intensive care unit. According to the report, Fitbit Labs also found a correlation between PAT and blood pressure in a small, three-week internal study. The new study will extend this work to a broader population in order to learn more about how PAT measurements change under a variety of conditions.Sense owners over 20 in the US will receive a notification in the Fitbit app about this study. If successful, the company sees having easy access to blood pressure readings as being potentially helpful for those with hypertension.--IANSvc/ksk/
San Francisco - Wearable brand Fitbit has rolled out a major update by making new health data available to Charge 4 users and expanding access to previously paywalled information to more users.
With the update, Charge 4 users will be able to access blood oxygen readings on the watchface, information that was previously available only through the app in sleep data.
The update also adds skin temperature data to the Charge 4, which wasn't offered previously on this device at all.
Charge 4, Versa 2 and Inspire 2 users can now also gain access to Health Metrics, which previously required a premium subscription. This dashboard shows trends for certain health metrics -- including breathing rate during sleep and heart rate variability -- over a recent period of time, The Verge reported on Wednesday.
Premium subscribers still get a little extra information, since their dashboards will show a full month's worth of information while the free version shows only seven days, the report said.
Fitbit, recently acquired by Google, also continues to expand access to its EKG feature on the Sense, making it available to customers in Canada, New Zealand and US territories.
This feature wasn't available in all regions when the device launched, but it was added in places like the US following regulatory approval. (IANS)
New Delhi, Dec 4 (IANS) Wearable brand Fitbit has offered replacements for some users of its Sense smartwatch after it discovered a bug in the electrocardiogram (ECG) feature that affected the readings, the media reported on Friday.The company has sent emails to the affected users warning that the devices are affected by an unspecified "hardware issue".Fitbit that has been acquired by Google for $2.1 billion introduced the ECG feature in the $329.95 Sense smartwatch in October that reads heart rhythm for conditions like atrial fibrillation (AFib). According to a report in The Verge, Fitbit has confirmed that the bug specifically affects the ECG functionality on a limited number of devices."Thanks for your purchase of Fitbit Sense. We identified a hardware issue with your device that could affect its ability to work properly. Please return the device to us. We'll provide you with a prepaid return label," the email read.The affected users will be given a replacement device free of charge."The problem means the app can incorrectly display an "inconclusive" result during readings. "Fitbit confirmed that no other devices, or future Sense smartwatches shipments, are affected by the issue," the report said.The smart wearable brand sold 3.3 million devices at an average selling price of $104 per device in the third quarter that ended on October 3.The company has introduced several new devices in the past 12 months, including Fitbit Charge 4, Fitbit Sense, Fitbit Versa 3 and Fitbit Inspire 2 -- representing 52 per cent of revenue.According to new data from the International Data Corporation (IDC), Fitbit and the Indian consumer electronics brand BoAt tied for fifth place in the third quarter, each holding 2.6 per cent of the global wearables market."Fitbit's new devices launched near the end of the quarter were relatively well received and a price drop on older models has helped the company stay within the Top 5," the IDC report said.--IANSna/
New Delhi, Sep 14 (IANS) Wearables brand Fitbit on Monday announced that it has received clearance from the US Food and Drug Administration (FDA), as well as the Conformite Europeenne(CE) marking in the European Union, for its electrocardiogram (ECG) app to assess heart rhythm for atrial fibrillation (AFib).Fitbit's on-device compatible ECG app aims to help analyse the heart's rhythm for signs of AFib. ECG is a measurement of the electrical activity of the heart, and with the Fitbit ECG App, people can take an on-the-spot reading of their heart rhythm at any time, including whenever they notice any unusual cardiac symptoms."Helping people understand and manage their heart health has always been a priority for Fitbit, and our new ECG app is designed for those users who want to assess themselves in the moment and review the reading later with their doctor," Eric Friedman, Fitbit co-founder and CTO, said in a statement.The Fitbit ECG App, unveiled in Fitbit's recent fall product launch, will be available from October 2020 onwards to users on Fitbit Sense in the following countries: the US, the UK, Germany, Austria, Luxembourg, the Netherlands, Sweden, Switzerland, Czech Republic, Poland, Belgium, Portugal, Romania, Ireland, Italy, Spain, France, Hong Kong and India.Fitbit Sense is the company's first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity AFib.As part of the submission process to regulatory agencies, Fitbit conducted a multi-site clinical trial in regions across the US.The study evaluated our algorithm's ability to accurately detect AFib from normal sinus rhythm and to generate an ECG trace, or recording of a heart's electrical rhythm, that is qualitatively similar to a Lead I ECG.--IANSwh/arm
San Francisco, Aug 29 (IANS) Tech billionaire Elon Musk has revealed his human brain-machine interface in greater details, this time in pigs who had prototypes of chips surgically implanted in their heads and their brain activity was tracked in real time during the demonstration.Referring to devices by his mysterious company Neuralink as a ‘Fitbit in your skull with tiny wires" several times during the presentation on Friday, Musk said he expects people with the ‘Link' chip in their heads to be able to "save and replay memories".Musk also announced that the US Food and Drug Administration (FDA) has awarded Neuralink a "breakthrough device authorisation" which can help expedite research on a medical device.The first clinical trial will focus on individuals with paraplegia or tetraplegia, resulting from cervical spinal cord injury. The company plans to enroll a "small number" of these individuals in order to test the efficacy and safety of the Neuralink technology, reports TechCrunch.Founded in 2016, Neuralink is developing high bandwidth brain-machine interfaces to connect humans and machines.While the touted benefits of the company's brain-machine interface range from providing anxiety relief to helping paralysed people control devices, the more immediate goal of the company appears to be allowing people to control their phones and computers with chips that can be implanted on the brain.Musk emphasized that a wide variety of spinal and neurological conditions can be treated with the Neuralink technology."These can all be solved with an implantable neural link. The neurons are like wiring, and you kind of need an electronic thing to solve an electronic problem," he said.The ultimate goal for Neuralink is a "full brain-machine interface" that will achieve a "symbiosis with artificial intelligence." The Tesla and SpaceX CEO has also claimed that a new Neuralink chip will allow users to hear sounds that previously were impossible to human ears."We're not trying to raise money or do anything else, but the main purpose is to convince great people to come work at Neuralink, and help us bring the product to fruition, make it affordable and reliable," Musk said at the event.--IANSna/